Utility Estimation in Chronic Obstructive Pulmonary Disease: A Preference for Change?

Author： Petrillo Jennifer  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.11, 2011-11, pp. : 917-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease?

By Bhatt Nitin Y.   Wood Karen L.  

Drugs & Aging, Vol. 25, Iss. 9, 2008-01 ,pp. : 717-728

Adis International

Access to resources Recommend Favorite

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?

By Miles Matthew C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 301-308

Adis International

Access to resources Recommend Favorite

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Is There a Clinical Benefit?

By Man S.F. Paul   Sin Don D.  

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 579-591

Adis International

Access to resources Recommend Favorite

Should Inhaled Corticosteroids be Used in the Long Term Treatment of Chronic Obstructive Pulmonary Disease?

By Burge S.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1535-1544

Adis International

Access to resources Recommend Favorite

Is Combination Therapy with Inhaled Anticholinergics and β 2 -Adrenoceptor Agonists Justified for Chronic Obstructive Pulmonary Disease?

By Reddy Chakravarthy B.   Kanner Richard E.  

Drugs & Aging, Vol. 24, Iss. 8, 2007-01 ,pp. : 615-628

Adis International

Access to resources Recommend Favorite